Brooke A. Schlappe

Brooke A. Schlappe

Oncology

2801 W Kinnickinnic River Pkwy
Ste 575
Milwaukee, WI 53215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high grade on pre-operative biopsy and low grade on hysterectomy specimen.

Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high grade on pre-operative biopsy and low grade on hysterectomy specimen.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 15, 2026

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis.

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis.

Journal: Gynecologic oncology reports

Published: June 27, 2022

Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study.

Assessment of wound perfusion with near-infrared angiography: A prospective feasibility study.

Journal: Gynecologic oncology reports

Published: January 04, 2022

Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.

Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.

Journal: Gynecologic oncology

Published: July 24, 2019

Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm.

Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm.

Journal: Gynecologic oncology

Published: July 02, 2019

A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen.

A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 18, 2019

Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.

Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.

Journal: Gynecologic oncology

Published: June 12, 2018

International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers.

International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 22, 2018

Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses.

Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses.

Journal: Gynecologic oncology

Published: March 01, 2018

Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18].

Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18].

Journal: Gynecologic oncology

Published: August 07, 2016

Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.

Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center.

Journal: Gynecologic oncology

Published: March 18, 2016

Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.

Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.

Journal: The American journal of surgical pathology

Published: December 10, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026